Liu, Minliang
Liang, Liang
Sulejmani, Fatiesa
Lou, Xiaoying
Iannucci, Glen
Chen, Edward
Leshnower, Bradley
Sun, Wei
Funding for this research was provided by:
American Heart Association (19PRE34430060, 18TPA34230083)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR002378)
Article History
Received: 18 February 2019
Accepted: 24 August 2019
First Online: 10 September 2019
Competing Interests
: Dr. Wei Sun is a co-founder and serves as the Chief Scientific Advisor of Dura Biotech. He has received compensation and owns equity in the company. The other authors declare no competing interests.